Universe Pharmaceuticals (UPC) Change in Acquisitions & Divestments: 2021-2024
- Universe Pharmaceuticals' Change in Acquisitions & Divestments rose 104.31% to $566,481 in Q1 2024 from the same period last year, while for Mar 2024 it was $13,219.0 billion, marking a year-over-year decrease of 7.84%. This contributed to the annual value of $13.2 million for FY2023, which is 0.54% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $566,481 for Q1 2024, which was down 100.00% from $13,219.0 billion recorded in Q3 2023.
- Over the past 5 years, Universe Pharmaceuticals' Change in Acquisitions & Divestments peaked at $14,344.1 billion during Q1 2022, and registered a low of -$13.1 million during Q1 2023.
- For the 3-year period, Universe Pharmaceuticals' Change in Acquisitions & Divestments averaged around $5,512.6 billion, with its median value being $13.1 million (2022).
- Within the past 5 years, the most significant YoY rise in Universe Pharmaceuticals' Change in Acquisitions & Divestments was 100,535,402.12% (2023), while the steepest drop was 100.00% (2023).
- Quarterly analysis of 4 years shows Universe Pharmaceuticals' Change in Acquisitions & Divestments stood at $13.7 million in 2021, then decreased by 4.20% to $13.1 million in 2022, then skyrocketed by 100,535,402.12% to $13,219.0 billion in 2023, then surged by 104.31% to $566,481 in 2024.
- Its Change in Acquisitions & Divestments stands at $566,481 for Q1 2024, versus $13,219.0 billion for Q3 2023 and -$13.1 million for Q1 2023.
